Search Results - jennifer+uhrlaub

2 Results Sort By:
Therapeutic Target to Attenuate Virus-Mediated Arthritis and Improve Immunity
This invention includes methods and pharmaceutics used to treat alphavirus infections by inhibiting specific cytokine production. These cytokines impair the immune response to the infection and causes inflammation, so its inhibition hastens recovery and diminishes symptom severity. Background: Varying immune response to alphaviral infections (specifically...
Published: 4/3/2023   |   Inventor(s): Janko Nikolich-Zugich, Jennifer Uhrlaub
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Therapeutics
Serological Assays for SARS-CoV-2
University of Arizona researchers have developed a serological assay to test for prior exposure to SARS-CoV-2. The technology uses a two-step protocol to maximize the specificity of the assay and reduce false positives. Background: In late 2019, a novel coronavirus appeared in Wuhan, China. Since that time, this virus has spread worldwide, impacting...
Published: 11/16/2023   |   Inventor(s): Deepta Bhattacharya, Ryan Sprissler, Janko Nikolich-Zugich, Tyler Ripperger, Jennifer Uhrlaub, Matthew Kaplan, Makiko Watanabe, Rachel Wong
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences